Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ascend Wellness HoldingsAAWH -3.10%49 EV-to-OCF is 51.27 as of Aug. 12, 2026, which is 537% above its 10-year median of 8.05. GuruFocus rates AAWH with a GF Score™ of 49/100 and a GF Value™ of $0.73 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 1,006 Drug Manufacturers companies, Ascend Wellness Holdings ranks worse than 87.97% on this metric.
The historical rank and industry rank for Ascend Wellness Holdings's EV-to-OCF or its related term are showing as below:
AAWH'
s EV-to-OCF Range Over the Past 10 Years
Min: -119.75 Med: 8.05 Max: 55.26
Current: 51.27
During the past 7 years, the highest EV-to-OCF of Ascend Wellness Holdings was 55.26. The lowest was -119.75. And the median was 8.05.
AAWH's EV-to-OCF is ranked worse than 87.97% of 1006
companies
in the Drug Manufacturers industry
Industry Median: 11.1
vs AAWH: 51.27
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Ascend Wellness Holdings's PE Ratio (TTM) for today is calculated as:
Ascend Wellness Holdings's share price for today is $0.407.
Ascend Wellness Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.640.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Ascend Wellness Holdings EV-to-OCF Related Terms
Ascend Wellness Holdings EV-to-OCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Ascend Wellness Holdings's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ascend Wellness Holdings EV-to-OCF vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Ascend Wellness Holdings's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Ascend Wellness Holdings's EV-to-OCF falls into.
Ascend Wellness Holdings's current Enterprise Value is $651.2 Mil.
Ascend Wellness Holdings's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $12.7 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ascend Wellness Holdings (AAWH) has a EV-to-OCF of 51.27 as of Aug. 12, 2026. This is 537% above median its historical median of 8.05. According to the industry distribution chart, Ascend Wellness Holdings ranks #885 out of 1006 companies in the Drug Manufacturers industry, placing it in the top 88%.
Is Ascend Wellness Holdings' EV-to-OCF too high?
Ascend Wellness Holdings' current EV-to-OCF of 51.27 is 537% above median its 10-year median of 8.05. The Drug Manufacturers industry median EV-to-OCF is 11.10. Ascend Wellness Holdings' value of 51.27 is 361.9% above this industry median. Based on the distribution chart, Ascend Wellness Holdings ranks #885 out of 1006 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Ascend Wellness Holdings has a GF Score™ of 49/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Ascend Wellness Holdings' EV-to-OCF compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Ascend Wellness Holdings ranks #885 out of 1006 companies for EV-to-OCF. This places Ascend Wellness Holdings in the lower half of its industry. The industry median EV-to-OCF is 11.10. Ascend Wellness Holdings' value of 51.27 is 361.9% above this benchmark. While the company's 10-year median is 8.05 vs. the industry median of 11.10, Ascend Wellness Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Drug Manufacturers company?
The median EV-to-OCF among Drug Manufacturers companies is 11.10, based on 1,006 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ascend Wellness Holdings's current EV-to-OCF of 51.27 is 361.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median EV-to-OCF is 11.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ascend Wellness Holdings's current EV-to-OCF is 51.27, which is 537% above median its own 10-year median of 8.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ascend Wellness Holdings stock overvalued right now?
Based on GuruFocus' analysis, Ascend Wellness Holdings (AAWH) is currently considered Possible Value Trap. The stock's GF Value™ is $0.73, compared to a current price of $0.41 — trading 44.2% below its estimated fair value. The current EV-to-OCF is 51.27, which is 537% above median its 10-year median of 8.05 and 361.9% above the Drug Manufacturers industry median of 11.10. Ascend Wellness Holdings' overall GF Score™ is 49/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Ascend Wellness Holdings (AAWH), the current EV-to-OCF is 51.27 as of Aug. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ascend Wellness Holdings (AAWH) Overvalued in 2026?
Based on GuruFocus' analysis, Ascend Wellness Holdings stock appears to be undervalued.
The current stock price of $0.41 is trading 44.2% below its estimated GF Value™ of $0.73.
GuruFocus considers Ascend Wellness Holdings to be Possible Value Trap.
Key valuation signals for AAWH:
EV-to-OCF: 51.27 (537% above median its 10-year median of 8.05)
GF Value™: $0.73 vs. price of $0.41 (44.2% below fair value)
Industry Position: 361.9% above the Drug Manufacturers median (#885 of 1006)
No single metric tells the full story. See the AAWH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ascend Wellness Holdings Inc is a vertically integrated multi-state operator focused on adult-use or near-term adult-use cannabis states in limited licenses markets. The company's core business is the cultivation, manufacturing, and distribution of cannabis consumer packaged goods, which it sells through company-owned retail stores and third-party licensed cannabis retail stores. It generates maximum revenue from the retail product segment.
49GF Score
Get the complete analysis for AAWH
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AAWH has been successfully added to your 
